Tenax Therapeutics, Inc. SEC filings TENX
Tenax Therapeutics, Inc. has 995 filings in SEC EDGAR's recent list, going back to Aug 2, 1996. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 10-Q | Quarterly report | Jul 31, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 17, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Nov 16, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 14, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 15, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Nov 14, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 14, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 15, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Nov 14, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 14, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | May 15, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Nov 9, 2017 | Sep 30, 2017 |
| 10-Q | Quarterly report | Aug 9, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | May 10, 2017 | Mar 31, 2017 |
| 10-Q | Quarterly report | Nov 9, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Aug 9, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | May 10, 2016 | Mar 31, 2016 |
| 10-Q | Quarterly report | Dec 10, 2015 | Oct 31, 2015 |
| 10-Q | Quarterly report | Sep 9, 2015 | Jul 31, 2015 |
| 10-Q | Quarterly report | Mar 17, 2015 | Jan 31, 2015 |
| 10-Q | Quarterly report | Dec 15, 2014 | Oct 31, 2014 |
| 10-Q | Quarterly report | Sep 15, 2014 | Jul 31, 2014 |
| 10-Q | Quarterly report | Mar 17, 2014 | Jan 31, 2014 |
| 10-Q | Quarterly report | Dec 17, 2013 | Oct 31, 2013 |
| 10-Q | Quarterly report | Sep 17, 2013 | Jul 31, 2013 |
| 10-Q | Quarterly report | Mar 18, 2013 | Jan 31, 2013 |
| 10-Q | Quarterly report | Dec 14, 2012 | Oct 31, 2012 |
| 10-Q | Quarterly report | Sep 19, 2012 | Jul 31, 2012 |
| 10-Q | Quarterly report | Mar 15, 2012 | Jan 31, 2012 |
| 10-Q | Quarterly report | Dec 15, 2011 | Oct 31, 2011 |
| 10-Q | Quarterly report | Sep 19, 2011 | Jul 31, 2011 |
| 10-Q | Quarterly report | Mar 21, 2011 | Jan 31, 2011 |
| 10-Q | Quarterly report | Dec 9, 2010 | Oct 31, 2010 |
| 10-Q | Quarterly report | Sep 9, 2010 | Jul 31, 2010 |
| 10-Q | Quarterly report | Mar 19, 2010 | Jan 31, 2010 |
| 10-Q | Quarterly report | Dec 11, 2009 | Oct 31, 2009 |
| 10-Q | Quarterly report | Sep 17, 2009 | Jul 31, 2009 |
| 10-Q | Quarterly report | Mar 16, 2009 | Jan 31, 2009 |
| 10-Q | Quarterly report | Dec 22, 2008 | Oct 31, 2008 |
| 10-Q | Quarterly report | Sep 22, 2008 | Jul 31, 2008 |
| 10-Q | Quarterly report | Mar 19, 2007 | Jan 31, 2007 |
| 10-Q | Quarterly report | Dec 1, 2006 | Oct 31, 2006 |
| 10-Q | Quarterly report | Sep 19, 2006 | Jul 31, 2006 |
| 10-Q | Quarterly report | Mar 17, 2006 | Jan 31, 2006 |
| 10-Q | Quarterly report | Dec 15, 2005 | Oct 31, 2005 |
| 10-Q | Quarterly report | Sep 14, 2005 | Jul 31, 2005 |
| 10-Q | Quarterly report | Mar 17, 2005 | Jan 31, 2005 |
| 10-Q | Quarterly report | Dec 15, 2004 | Oct 31, 2004 |
| 10-Q | Quarterly report | Sep 14, 2004 | Jul 31, 2004 |
| 10-Q | Quarterly report | Mar 16, 2004 | Jan 31, 2004 |
| 10-Q | Quarterly report | Dec 19, 2003 | Oct 31, 2003 |
| 10-Q | Quarterly report | Sep 19, 2003 | Jul 31, 2003 |
| 10-Q | Quarterly report | Mar 12, 2003 | Jan 31, 2003 |
| 10-Q | Quarterly report | Dec 13, 2002 | Oct 31, 2002 |
| 10-Q | Quarterly report | Sep 12, 2002 | Jul 31, 2002 |
| 10-Q | Quarterly report | Mar 15, 2002 | Jan 31, 2002 |
| 10-Q | Quarterly report | Dec 12, 2001 | Oct 31, 2001 |
| 10-Q/A | Amended quarterly report | Sep 12, 2001 | Jul 31, 2001 |
| 10-Q | Quarterly report | Mar 16, 2001 | Jan 31, 2001 |
| 10-Q | Quarterly report | Dec 14, 2000 | Oct 31, 2000 |
| 10-Q | Quarterly report | Sep 14, 2000 | Jul 31, 2000 |
| 10-Q | Quarterly report | Mar 16, 2000 | Jan 31, 2000 |
| 10-Q | Quarterly report | Dec 14, 1999 | Oct 31, 1999 |
| 10-Q | Quarterly report | Sep 14, 1999 | Jul 31, 1999 |
| 10-Q | Quarterly report | Mar 17, 1999 | Jan 31, 1999 |
| 10-Q | Quarterly report | Dec 15, 1998 | Oct 31, 1998 |
| 10-Q | Quarterly report | Sep 14, 1998 | Jul 31, 1998 |
| 10-Q | Quarterly report | Mar 17, 1998 | Jan 31, 1998 |
| 10-Q | Quarterly report | Dec 15, 1997 | Oct 31, 1997 |
| 10-Q | Quarterly report | Sep 12, 1997 | Jul 31, 1997 |
| 10-Q | Quarterly report | Mar 13, 1997 | Jan 31, 1997 |
| 10-Q | Quarterly report | Dec 16, 1996 | Oct 31, 1996 |
| 10-Q | Quarterly report | Sep 13, 1996 | Jul 31, 1996 |
Showing 89 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TENX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Chapel Hill, NC
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 34956
- Former names
- OXYGEN BIOTHERAPEUTICS, INC. (until Sep 15, 2014); SYNTHETIC BLOOD INTERNATIONAL INC (until Jun 30, 2008)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.